We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
-3.28%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$15.4B
AUM Growth
+$3.25B
(+27%)
Cap. Flow
+$3.84B
Cap. Flow
% of AUM
24.9%
Top 10 Holdings %
Top 10 Hldgs %
24.83%
Holding
2,819
New
321
Increased
2,347
Reduced
46
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$246M |
| 2 |
Microsoft
MSFT
|
+$216M |
| 3 |
Amazon
AMZN
|
+$130M |
| 4 |
Tesla
TSLA
|
+$79.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$73.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$49.3M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$11.7M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$11.6M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.56M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$5.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 12.21% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
2626
DELISTED
Mersana Therapeutics
MRSN
| $99.6K | ﹤0.01% |
999
-82
| -8% | -$9.58K |
|
2627
Aveanna Healthcare
AVAH
$1.97B
| $98.6K | ﹤0.01% |
28,914
+10,246
| +55% | +$55.6K |
|
|
CLR
2628
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $98.1K | ﹤0.01% |
+1,599
| New | +$88.7K |
|
2629
Rocket Companies
RKT
$39.8B
| $97K | ﹤0.01% |
+8,726
| New | +$108K |
|
|
AL
2630
DELISTED
Air Lease Corp
AL
| $95.5K | ﹤0.01% |
+2,139
| New | +$89.6K |
|
2631
DoubleVerify
DV
$2.04B
| $95.1K | ﹤0.01% |
+3,777
| New | +$98.3K |
|
2632
Rithm Capital
RITM
$5.71B
| $95K | ﹤0.01% |
+8,650
| New | +$91.7K |
|
2633
Hyatt Hotels
H
$16.8B
| $94.3K | ﹤0.01% |
+988
| New | +$92.7K |
|
2634
AXIS Capital
AXS
$7.26B
| $93.6K | ﹤0.01% |
+1,548
| New | +$86.2K |
|
2635
ChargePoint
CHPT
$166M
| $90.6K | ﹤0.01% |
+228
| New | +$70.3K |
|
2636
Adaptive Biotechnologies
ADPT
$4.02B
| $90.4K | ﹤0.01% |
+6,510
| New | +$102K |
|
|
HT
2637
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $87.9K | ﹤0.01% |
9,680
-1,797
| -16% | -$16.6K |
|
2638
Amylyx Pharmaceuticals
AMLX
$2.6B
| $87.2K | ﹤0.01% |
+6,785
| New | +$153K |
|
2639
Noodles & Co
NDLS
$98M
| $87.1K | ﹤0.01% |
1,823
+242
| +15% | +$14.9K |
|
2640
Howard Hughes
HHH
$3.98B
| $85.9K | ﹤0.01% |
+870
| New | +$80.2K |
|
2641
Assured Guaranty
AGO
$3.29B
| $85.7K | ﹤0.01% |
+1,346
| New | +$77.2K |
|
|
LSXMA
2642
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $84.9K | ﹤0.01% |
+2,527
| New | +$88.8K |
|
2643
Herbalife
HLF
$1.23B
| $84.3K | ﹤0.01% |
+2,777
| New | +$109K |
|
|
PINC
2644
DELISTED
Premier
PINC
| $84.3K | ﹤0.01% |
+2,368
| New | +$88.2K |
|
2645
Iovance Biotherapeutics
IOVA
$3.05B
| $83.3K | ﹤0.01% |
+5,005
| New | +$77.4K |
|
2646
SelectQuote
SLQT
$124M
| $80K | ﹤0.01% |
28,677
-13,906
| -33% | -$67K |
|
2647
Spectrum Brands
SPB
$2.03B
| $78K | ﹤0.01% |
879
+800
| +1,013% | +$73.6K |
|
2648
Commercial Vehicle Group
CVGI
$128M
| $77.9K | ﹤0.01% |
9,220
-2,477
| -21% | -$20.1K |
|
2649
CarParts.com
PRTS
$48.7M
| $76.9K | ﹤0.01% |
1,147
-588
| -34% | -$50.6K |
|
2650
Allegro MicroSystems
ALGM
$7.92B
| $73.8K | ﹤0.01% |
+2,597
| New | +$74.2K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q1 2022 Portfolio in Review
As of Q1 2022, MetLife Investment Management held 2,819 positions worth $15.4B, up 27% from $12.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
MetLife Investment Management deployed $3.84B of net new capital in Q1 2022, opening 321 new positions and adding to 2,347 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $49.3M trimmed.
- MetLife Investment Management's largest Q1 2022 buy was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
- MetLife Investment Management added most to Apple in Q1 2022, an estimated $246M increase.
- MetLife Investment Management's biggest Q1 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $49.3M.
- MetLife Investment Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $11.7M.
- MetLife Investment Management's ten largest holdings make up 25% of its $15.4B portfolio in Q1 2022.
- MetLife Investment Management opened 321 new positions and closed 92 in Q1 2022.
- MetLife Investment Management's portfolio value rose 27% quarter-over-quarter to $15.4B.
Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.